Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis

Data Supplement

Files in this Data Supplement:

• Supplemental Figures -

  Supplemental Figure 1: Candesartan has no effect on long-term prostate cancer cell proliferation in vitro. Supplemental Figure 2: Candesartan inhibits VEGF expression in prostate cancer DU145 cells in vitro in a dose-dependent manner.